잠시만 기다려 주세요. 로딩중입니다.

Diagnostic Performance of 68Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-analysis

The World Journal of Men′s Health 2020년 38권 2호 p.208 ~ 219
Wu Hui, Xu Ting, Wang Xiao, Yu Yong-Bo, Fan Zhong-Yuan, Li Dan-Xia, Luo Lei, Yang Xue-Cheng, Jiao Wei, Niu Hai-Tao,
소속 상세정보
 ( Wu Hui ) - Qingdao University Affiliated Hospital Department of Urology
 ( Xu Ting ) - 971th Hospital of PLA Department of Geratology
 ( Wang Xiao ) - Qingdao University Affiliated Hospital Department of Urology
 ( Yu Yong-Bo ) - Qingdao University Affiliated Hospital Department of Urology
 ( Fan Zhong-Yuan ) - Qingdao University Affiliated Hospital Department of Urology
 ( Li Dan-Xia ) - Qingdao University Affiliated Hospital Department of Urology
 ( Luo Lei ) - Qingdao University Affiliated Hospital Department of Urology
 ( Yang Xue-Cheng ) - Qingdao University Affiliated Hospital Department of Urology
 ( Jiao Wei ) - Qingdao University Affiliated Hospital Department of Urology
 ( Niu Hai-Tao ) - Qingdao University Affiliated Hospital Department of Urology

Abstract


Purpose: To compare the diagnostic efficiency of 68Gallium labelled prostate-specific membrane antigen positron emission tomography (68Ga-PSMA PET) and magnetic resonance imaging (MRI) for staging the lymph node metastases (LNMs) in the prostate cancer.

Materials and Methods: A broad search of scientific databases including PubMed, EMBASE, Web of Science, Cochrane Database, and Chinese Biomedicine Literature Database (updated prior to November 1st, 2018) was conducted systematically by two reviewers. In this paper, we evaluated the methodological quality of each included article independently and performed a systematic review and meta-analysis to reveal the summary of the diagnostic performance of 68Ga-PSMA PET and MRI in properly identifying LNMs of intermediate- and/or high-risk prostate cancer.

Results: Thirteen eligible articles comprising 1,597 patients were included. For LNMs detection, the pooled sensitivity and specificity of 68Ga-PSMA PET were 0.65 (95% confidence interval [CI]: 0.49?0.79) and 0.94 (95% CI: 0.88?0.97), respectively, while the corresponding values of MRI were 0.41 (95% CI: 0.26?0.57) and 0.92 (95% CI: 0.86?0.95). The area under the symmetric receiver-operating characteristic (SROC) curve for 68Ga-PSMA PET and MRI were 0.92 and 0.83, respectively.

Conclusions: In intermediate- or high-risk pre-treatment prostate cancer, 68Ga-PSMA PET had a higher sensitivity and a slightly different specificity in probing the LNMs when comparing with MRI. Moreover, the area under the SROC curve indicated that 68Ga-PSMA PET was a more effective weapon for predicting the LNMs prior to radical surgery.

키워드

Magnetic resonance imaging; Metastasis; Meta-analysis; Positron-emission tomography; Prostate cancer

원문 및 링크아웃 정보

 

등재저널 정보

SCI(E)
KCI
KoreaMed